Human Genome Sciences Inc's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the second quarter 2012 to a ratio of 3.25, above the company average. This is a clear sign of healthy business climate in the Medical Laboratories industry and improving liquidity at their respective customers, during the second quarter 2012. Average receivable collection period, for the Human Genome Sciences Inc in Jun 30 2012 quarter, has decreased to 112 days, compared to 126 days, in the Mar 31 2012 quarter.

If we take a look into Healthcare sector 272 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Jun 30 2012 from to 2879.

What is Receivable Turnover Ratio?
What is Human Genome Sciences Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

HGSI Receivables Turnover Ratio	(Jun 30 2012) II. Quarter	(Mar 31 2012) I. Quarter	(Dec 31 2011) IV. Quarter	(Sep 30 2011) III. Quarter	(Jun 30 2011) II. Quarter
Y / Y Receivable Change	52.11 %	315.46 %	110.95 %	-	-
Y / Y Revenue Change	142.75 %	77.35 %	114.09 %	-33 %	-35.92 %
Receivable Turnover Ratio (TTM)	3.25	2.89	3.38	3.38	6.04
HGSI's Total Ranking	# 2879	#	#	#	#
Accounts Receivable average collection period days	112	126	108	108	60
Seq. Receivable Change	-19.54 %	32.39 %	23.22 %	15.9 %	119.75 %
Seq. Revenue Change	28.04 %	3.53 %	33.8 %	36.87 %	-6.45 %

Receivable Turnover Company Ranking
Within:	No.
Medical Laboratories Industry	# 21
Healthcare Sector	# 273
Overall Market	# 2879

Receivable Turnover Ratio Statistics
High	Average	Low
0.15	0.13	0.11
(Jun 30 2012)		(Dec 31 2011)

HGSI Company Profile • Back to HGSI Efficiency Comparisons • Compare HGSI Receivables Turnover Ratio to its Competitors

Financial Statements
Human Genome Sciences Inc's Accounts Receivable	$ 58 Millions	Visit HGSI's Balance sheet
Human Genome Sciences Inc's Sales TTM	$ 187 Millions	Visit HGSI's Income Statement
Sources of HGSI's Revenues		Visit HGSI's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Laboratories Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
HGSI's Receivable Turnover Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
HGSI's Growth Rates	HGSI's Roa	HGSI's Inventory Turnover Ratio	HGSI's Dividend Comparisons
HGSI's Profitability Ratios	HGSI's Roi	HGSI's Asset Turnover Ratio	HGSI's Dividend Growth
HGSI's Valuation Ratios	HGSI's Roe	HGSI's Financial Strength Ratios	HGSI's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2012, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Jun 30 2012	Receivable at quarter ending Jun 30 2012
Genmark Diagnostics Inc	8.76	$ 9.121 Millions	$ 1.041 Millions
Icu Medical Inc	8.76	$ 305.720 Millions	$ 34.912 Millions
Stablecoin Development Corporation	8.70	$ 6.193 Millions	$ 0.711 Millions
Idexx Laboratories Inc	8.67	$ 1,266.480 Millions	$ 146.085 Millions
Utah Medical Products Inc	8.67	$ 41.921 Millions	$ 4.836 Millions
Chembio Diagnostics Inc	8.66	$ 24.875 Millions	$ 2.872 Millions
Merit Medical Systems Inc	8.66	$ 377.719 Millions	$ 43.634 Millions
Zogenix Inc	8.63	$ 44.676 Millions	$ 5.174 Millions
Adm Tronics Unlimited Inc	8.60	$ 1.938 Millions	$ 0.225 Millions
Rti Surgical Holdings Inc	8.59	$ 174.128 Millions	$ 20.276 Millions
Precision Optics Corporation Inc	8.48	$ 1.816 Millions	$ 0.214 Millions
Sangamo Therapeutics Inc	8.46	$ 14.421 Millions	$ 1.705 Millions
Dynatronics Corporation	8.45	$ 31.664 Millions	$ 3.746 Millions
Biogen Inc	8.45	$ 5,349.599 Millions	$ 633.435 Millions
Nektar Therapeutics	8.44	$ 84.483 Millions	$ 10.004 Millions
Cantel Medical Corp	8.41	$ 386.490 Millions	$ 45.964 Millions
Patterson Companies Inc	8.30	$ 3,577.464 Millions	$ 430.989 Millions
Insulet Corporation	8.26	$ 190.575 Millions	$ 23.062 Millions
Halozyme Therapeutics Inc	8.22	$ 40.551 Millions	$ 4.935 Millions
First Choice Healthcare Solutions Inc	8.10	$ 1.222 Millions	$ 0.151 Millions
Quest Diagnostics Inc	8.09	$ 7,597.893 Millions	$ 939.529 Millions
Ufp Technologies Inc	8.05	$ 127.864 Millions	$ 15.879 Millions
Repligen Corp	8.05	$ 44.145 Millions	$ 5.486 Millions
Icad Inc	7.99	$ 26.936 Millions	$ 3.371 Millions
Axogen inc	7.98	$ 6.168 Millions	$ 0.773 Millions
Vertex Pharmaceuticals Inc	7.95	$ 2,079.582 Millions	$ 261.661 Millions
Masimo Corp	7.92	$ 463.909 Millions	$ 58.607 Millions
Jazz Pharmaceuticals Plc	7.89	$ 394.782 Millions	$ 50.019 Millions
Altimmune inc	7.87	$ 20.567 Millions	$ 2.614 Millions
Luminex Corporation	7.84	$ 190.426 Millions	$ 24.283 Millions

Date modified: 2026-09-08T15:07:12+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.